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Abstract
Efferocytosis is the clearance of apoptotic cells and is necessary for homeostasis. Mer
Tyrosine Kinase (MerTK) is a crucial efferocytic receptor whose loss is associated with
chronic inflammatory diseases and autoimmunity. While previous studies have shown that
MerTK mediates efferocytosis through a unique mechanism that requires integrins, MerTK
signalling pathway remains unknown. Given this unusual internalization mechanism, I
hypothesized that MerTK signals and engages integrins through a novel signalling pathway
different from that used by other phagocytic receptors. Therefore, this study aimed to identify
the signalling pathways activated by MerTK, utilizing conventional cell biology and
pharmacological approaches.
I found that M0 and M2, but not M1 primary human macrophages, expressed MerTK.
Moreover, crosslinking MerTK induced endocytosis in a MerTK-dependent manner, which
was independent of the common regulators of phagocytosis. Furthermore, crosslinking
MerTK resulted in intracellular tyrosine phosphorylation partially dependent on Syk/Srcfamily kinases and PI3-kinase, which denote their importance in MerTK tyrosine
phosphorylation.
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Chapter 1: Introduction
Efferocytosis is the engulfment of apoptotic cells by phagocytes and is necessary for the
maintenance of homeostasis. Apoptotic cells present “eat-me” signals on their cell
membrane which act as ligands to enable their recognition by phagocytic receptors.
These receptors mediate the uptake and degradation of apoptotic cells in an antiinflammatory and non-immunogenic fashion. If efferocytosis is defective, apoptotic cells
remain uncleared and eventually undergo secondary necrosis. This releases proinflammatory intracellular contents and self-antigens into the surrounding tissues, and
suppresses the secretion of anti-inflammatory cytokines, thereby promoting inflammation
and autoimmunity 1. MerTK plays an important role in efficient efferocytosis and is
required for prevention of the damaging effects of incomplete efferocytosis. Indeed,
studies of MerTK mutants and genome-wide association studies have shown MerTK to
be critical in the prevention of chronic inflammatory diseases such as atherosclerosis and
autoimmune disorders such as lupus 2,3.

1.1 Apoptosis signalling pathway
Apoptosis is defined as programmed cell death that occurs as a normal part of
development and homeostasis of cell population 4. There are two main pathways of
apoptosis: the extrinsic pathway which is triggered by pro-apoptotic ligands (example,
first apoptosis signal ligand,) binding onto death receptors (example, first apoptosis
signal), and the intrinsic pathway, which induces apoptosis in response to noxious
cellular stimuli generated by free radicals or lack of growth factors. Both pathways
activate cysteine-aspartic proteases (caspases) that play crucial role in apoptosis 2.
Caspases are synthesized in inactive forms called pro-caspases in which their catalytic
domains are inhibited by the adjacent pro-domains 5,6. Activation occurs when the prodomain of the caspase is cleaved, thus uninhibiting the proteolytic domain. Caspases can
be divided into two classes: initiator and effector caspases. Initiator caspases (caspase-8,
9, and 10) cleave and activate other caspases, while effector caspases (caspase-3, 6, and
7) cleave other cellular effectors that mediate the cellular changes associated with
apoptosis 5. These effectors are important in mediating the removal of apoptotic cells. For
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example, caspase-3 targets caspase-activated DNase, which degrades DNA during
apoptosis, allowing the nuclear components to be dispersed throughout the forming
apoptotic bodies. Many other effector proteins are involved in the degradation and
packaging of apoptotic cellular materials 7,8. The combined activity of these proteins
produces the typical morphological hallmarks of apoptosis such as nuclear fragmentation,
deliberate disassembly of subcellular organelles, re-distribution of plasma membrane
lipids, and packaging of cellular contents into blebs. Apoptotic blebs are protrusions of
plasma membrane that form by actin-myosin contraction of the cortical actin
cytoskeleton. These blebs contain the degraded cytoplasmic materials and organelles
produced during apoptosis, and pinch off from the apoptotic cell to form apoptotic bodies
which can then be efferocytosed 9,10. The small size of apoptotic bodies make them easy
targets for phagocytes, being much easier for phagocytes to engulf than intact cells.

1.2 Recognition, engulfment, and processing of apoptotic
cells
The identification and removal of apoptotic cells is a three-step process in which
phagocytes are recruited to the site of apoptosis by “find-me” signals, engage and engulf
the apoptotic cell through “eat-me” signals displayed on the apoptotic cell surface, and
finally degrade the apoptotic cell. In the first step of this process, apoptotic cells release
find-me signals which act as chemoattractants to recruit phagocytes. These find-me
signals include ATP, UTP, fractalkine, lysophosphatidylcholine (LPC), and sphingosine1-phosphate 11. The mechanisms leading to the release of most of these find-me signals
are not well understood, with the exception of LPC which is released from apoptotic cells
by a caspase-8-dependent activation of phospholipase A2 (PLA2). PLA2 cleaves
phosphatidylcholine to LPC then LPC binds to the G-protein-coupled receptor, G2A,
found on phagocytes such as macrophages, thereby enabling macrophage recruitment to
the vicinity of the apoptotic cell 7,12. ATP and UTP signals through purinergic G-proteincoupled receptors such as P2Y2, but their mechanism of release from apoptotic cells
remains unclear 13. Fractalkine is only released by a few subsets of apoptotic cells,
typically being released from apoptotic immune cells, and signals through the CX3CR1
chemokine receptor 14.
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Binding and engulfment of apoptotic cells are mediated by binding of “eat-me” signals
on the apoptotic cell to efferocytic receptors on the phagocyte. Among these eat-me
signals are phosphatidylserine, calreticulin, oxidized lipids and DNA. In most healthy
cells, phosphatidylserine is confined to the inner leaflet of plasma membrane 9,15. This
plasma membrane asymmetry is lost during apoptosis through the activation of lipid
scramblases, leading to the exposure of normally intracellular lipids on the surface of
apoptotic cells. Phosphatidylserine exposure is insufficient for efferocytosis, as evidenced
by the presence of phosphatidylserine on healthy T and B-cells and on platelets 16,17.
Efferocytosis of these cells is impaired, in part, by the presence of “don’t-eat-me” signals
such as CD31 and CD47, which are shed or otherwise downregulated during apoptosis
11,16

. Moreover, the concordant recognition of multiple eat-me signals may provide

sufficient pro-efferocytic signalling to overcome the inhibitory effect of these don’t-eatme receptors. While phosphatidylserine is the best understood eat-me signal, it is clear
that other eat-me signals play an important role in efferocytosis. Characterization of the
other eat-me signals is on-going, but it is established that calreticulin is transported from
the endoplasmic reticulum to the plasma membrane following endoplasmic reticulum
stress, likely via the canonical endoplasmic reticulum-golgi secretion pathway 14,18.
Oxidized LDL are generated by apoptosis-induced oxidants, and are recognized by
efferocytic receptors including CD36 and other scavenger receptors 19. Although
controversial, there is some evidence that mitochondrial or nuclear DNA may be exposed
on the cell surface where it then acts as an eat-me signal which engages CD91 receptor 20.
Some efferocytic receptors directly bind to these eat-me signals while others require
bridging molecules. For example, T-cell Immunoglobulin Mucin family, Brain-specific
Angiogenesis Inhibitor-1 , and Stablin-2 receptors directly bind to phosphatidylserine on
apoptotic cells 21–23, while MerTK and αvβ3 integrin bind to phosphatidylserine through
bridging molecules 16.
After recognizing eat-me signals on apoptotic cells, the phagocyte internalizes the
apoptotic cell through actin reorganization, leading to the apoptotic cells being
internalized into a membrane-bound vacuole termed efferosome in which it is degraded.
It is not fully established how this degradation is achieved, but evidence from our lab
demonstrates that efferosome maturation progresses through the canonical Rab5-Rab7
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maturation pathway, but then recruits novel trafficking regulators at the lysophagosomal
stage which may act to direct apoptotic-cell derived antigens away from MHC loading
compartments. These experiments demonstrated that many of the regulators and vesicle
fusion events that regulate the processing of phagocytic and endocytic cargos are required
for the degradation of apoptotic cells (example, Rab5, Rab7, lysosomal fusion; reviewed
in 24). We also found that unique proteins were recruited to the maturing efferosomes,
perhaps accounting for the lack of antigen presentation and inflammation following
efferocytosis (unpublished data, work by Y. Kim).

1.3 General characteristics of MerTK
1.3.1

MerTK structure and signalling

MerTK is a receptor tyrosine kinase consisting of an extracellular domain with two
immunoglobulin-like domains and two fibronectin III motifs, a transmembrane domain,
and an intracellular kinase domain 25. It shares these features with Tyro-3 and Axl
receptors making it part of the TAM (Tyro-3, Axl, Mer) subfamily 26. MerTK is
expressed in cells of myeloid, epithelial, and reproductive origin. In the myeloid lineage,
it is expressed in macrophages, dendritic cells, and platelets 27. Furthermore,
overexpression of MerTK has been associated with oncogenic transformation in human
malignancies such as colon, esophageal, and lung cancers 28.
MerTK is required for normal clearance of apoptotic cells, as shown by Sather, et al. 25
where soluble MerTK inhibited clearance of apoptotic cells. It is common for membranebound receptors to generate a soluble form through proteolytic cleavage of the
extracellular domain by metalloproteinase 25. This proteolytic cleavage of receptor
tyrosine kinases generally functions to limit signalling through the receptor by
eliminating the receptor’s ligand-binding capabilities, thus contributing to homeostasis
through maintaining normal levels of the receptor tyrosine kinases 25. However, this
cleavage can also impair receptor-mediated processes if excessive cleavage occurs. The
study by Sather et al. 25 revealed that the extracellular domain of MerTK was cleaved by
the metalloproteinase, TNF-α Converting Enzyme (TACE), resulting in a soluble form of
MerTK. This cleavage was induced in vitro after treatment of the cells with phorbol
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myristate acetate and lipopolysaccharide (LPS). The shed extracellular domain of MerTK
then acted as a decoy receptor by binding to and sequestering Growth Arrest Specific-6
(Gas-6). Sequestering Gas-6 was sufficient to impair MerTK activation, and thus impede
macrophage engulfment of apoptotic cells 25. This was confirmed by addition of TNF-α
Processing Inhibitor-0, a TACE inhibitor, which blocked MerTK shedding and restored
normal efferocytosis.

1.3.2

MerTK opsonins

The importance of opsonins to MerTK function was first identified in platelets. MerTK
ligation induces platelet degranulation and aggregation, thus mice lacking MerTK have
platelet dysfunctions 29. Investigations into the natural ligand that induced MerTKdependent platelet aggregation led to the discovery that MerTK was not directly binding
phosphatidylserine on activated platelets but was interacting via the opsonin, Gas-6. Later
studies showed that MerTK not only engaged degranulating platelets, but also apoptotic
cells, and revealed several other opsonins, such as Protein S, Tubby, and Tubby-Like
Protein 1 (Tulp1), which could mediate the interaction between MerTK and apoptotic
cells. Gas-6 and Protein S are gamma-carboxylated in a vitamin K-dependent manner,
and act to bridge phosphatidylserine on apoptotic cells through their N-terminal Gla
domain to MerTK through their C-terminal laminin G-like 30. Tubby and Tulp1 are
phosphatidylinositide-binding intracellular transcription factors that are secreted through
a non-canonical secretion pathway in the extracellular milieu 31, and facilitate Retinal
Pigment Epithelial (RPE) cells efferocytosis. Caberoy et al. 31 demonstrated that Tubby
and Tulp1 induce efferocytosis through activating MerTK. Tubby and Tulp1 bind to
PI(4,5)P2 on apoptotic cells through their C-terminal Polyphosphate Binding Domain and
to MerTK through their N-terminal Muramyl Dipeptide region 31. The binding of MerTK
to opsonins on apoptotic cells results in clustering of MerTK, leading to
autophosphorylation of MerTK kinase domain and thus activation of MerTK signalling
and internalization of the apoptotic cells 32,33.
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1.3.3

Discovery of MerTK as an efferocytic receptor

The function of MerTK was first discovered in the RPE phagocytic model of congenital
blindness. The RPE is a monolayer of cells crucial for proper functioning of the retina.
Aside from providing a protective layer over top of the photosensitive layer of the eye,
RPE cells also clear the eye of apoptotic debris – in particular the continually shed outer
segments of photoreceptor cells 34. This shedding prevents buildup of toxic oxidative
products within the photosensitive cells of the eye through an apoptosis-like process in
which the oldest portion of the cell (the outer segment disc) is shed, displays eat-me
signals, and is then phagocytosed by an adjacent RPE cell 34. The RPE model was used to
define the overall process of efferocytosis: recognition, binding/engulfment, and
degradation of the apoptotic target 34. MerTK was revealed to be central to RPE
phagocytosis in these studies. Specifically, researchers studied the causative agent of
retinal dystrophy in the Royal College of Surgeon (RCS) rat model (a rat model of
recessively inherited retinal degeneration) 34,35. They found that in these rats, shed
photoreceptor rod outer segments were bound by RPE cells but not internalized, leading
to a histologically observable accumulation of outer segment debris. D’Cruz et al. 35 used
positional cloning to identify the retinal dystrophy loci and discovered that this loci
contained a mutation in the MerTK gene. An identical phenotype was observed when
MerTK was knocked out in mice, confirming the role of the receptor in the RPE model 36.
This phenotype is recapitulated in humans carrying similar recessive mutations in the
MerTK loci 37. This demonstrates that MerTK is an essential receptor in clearance of
shed photoreceptor outer segment in the retina, with mutation in MerTK being
responsible for some cases of human juvenile retinal dystrophy 35.

1.3.4

MerTK in autoimmunity and inflammation

In addition to its role in maintaining vision through the removal of apoptotic outer rod
segments, MerTK plays a broader role in maintaining homeostasis. It is established that
when there is a defect in clearance of apoptotic cells, apoptotic cells are left uncleared.
Over time these cells lose metabolic capacity, eventually degrading and undergoing
secondary necrosis 14. These uncleared apoptotic cells release intracellular components,
some of which are pro-inflammatory, into the extracellular space. These cellular
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components, termed alarmins or danger signals, activate immune cells and induce
inflammation 38. Combined with the release of self-proteins, the release of these alarmins
may contribute to induction of autoimmunity 38.
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease closely tied to
failures in efferocytosis. SLE patients express a wide range of clinical manifestations
affecting multiple systems such as the nervous, respiratory, cardiovascular, and renal
system. A key clinical feature of SLE is the presence of anti-nuclear antibodies in patient
sera, likely produced in response to the release of DNA and histones during secondary
necrosis 7,39. Cohen et al. 3 reported that mice lacking the intracellular kinase domain of
MerTK show delayed clearance of exogenously administered apoptotic cells in vivo. The
mice developed serological manifestation of lupus including autoantibodies to ssDNA,
dsDNA, and IgG, and production of rheumatoid factor. This study also observed that
since the extracellular portion of MerTK was still intact, apoptotic cells were being bound
but not internalized indicating that physical clearance from the intracellular space was the
key step in preventing this lupus-like autoimmunity. Therefore, accumulation of
apoptotic cell is a stimulus for systemic autoimmune disease 3. Furthermore, Recarte-Pelz
et al. 40 examined the genetic profiles and plasma concentrations of Gas-6, Protein S, and
soluble forms of TAM receptors in SLE patients. They discovered increased soluble form
of Gas-6 and TAM receptors in the SLE patients but decreased soluble form of Protein S,
suggesting that opsonin availability and differences in opsonin activity may correlate
with disease onset or activity in SLE 40.
In addition to preventing autoimmunity, MerTK also plays a role in preventing chronic
inflammatory diseases such as atherosclerosis. Atherosclerosis is a cardiovascular disease
characterized by hardening and thickening of the artery due to plaque formation 41. There
is evidence that impaired efferocytosis of dying cells is linked to progression of
atherosclerosis 2,42. The pathophysiology of atherosclerosis begins with infiltration of
macrophages and immune cells into the tunica intima of an artery in response to the
deposition of Low-Density Lipoprotein (LDL) and the subsequent release of
apolipoprotein B-100 in the intima 41. Macrophages are recruited to these sites, where
they internalize the cholesterol-rich LDL (a process that produces severe cell stress),

8

leading the macrophages to differentiate into foam cells and eventually become apoptotic.
These foam cells are not cleared via efferocytosis, leading to an accumulation of
secondary necrotic debris in the core of the lesion 2,43. As the lesion matures it loses
stability, eventually rupturing and producing an intravascular thrombus. If this thrombus
detach, it can lodge in smaller vessels within the heart or brain producing a myocardial
infarct or ischemic stroke, respectively 44.
A key feature of the atherosclerotic environment is the accelerated apoptosis of
macrophages and smooth muscle cells along with defective removal of the dying cells,
leading to an accumulation of necrotic cells 41. This accumulation of necrotic cells
appears to be due to defective or impaired efferocytosis, as indicated in a study by Thorp
et al. 43. In this study, kinase-defective MerTK/ApoE-/- mice macrophages were unable to
clear cholesterol-induced apoptotic macrophages in vitro, which suggest that MerTK
plays an important role in efferocytosis in atheroma. Moreover, Ait-Oufella et al. 42
examined the role of MerTK in atherosclerosis by irradiating and reconstituting
atherosclerotic-susceptible mice with MerTK-/- or MerTK+/+ bone marrow. After the mice
were subjected to high fat diet, MerTK-/- mice had apoptotic cell accumulation within
atherosclerotic lesion, accelerated lesion development, and a stronger pro-inflammatory
immune response. This suggests that MerTK is important for bone marrow-derived cell
efferocytosis and control of inflammation 42.
Human studies have linked MerTK with atherosclerosis for instance, the study by
Hurtado et al. 45 provided a link between Gas-6 and carotid atherosclerosis. Analysis of
the genetic link between Single-Nucleotide Polymorphisms (SNPs) and haplotypes in
Gas-6-TAM genes and carotid atherosclerosis led to discovery that SNPs in Tyro3 and
MerTK were associated with carotid atherosclerosis, which highlights a role of the Gas6-TAM pathway in atherosclerosis. When Hurtado et al. 46 studied mRNA and protein
expression of Gas-6, Protein S, and TAM receptors in human atherosclerotic carotid
arteries, they noticed increased MerTK and Protein S in the atherosclerotic arteries versus
normal arteries. While the source of the MerTK and Protein S was unclear, the expression
profile of these genes in healthy individuals would suggest that they are most likely
expressed on cells of a myeloid origin example, macrophages infiltrating the lesion site.
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The previously mentioned studies demonstrating that MerTK function to reduce
cellularity in atherosclerotic plaques suggest that this increased expression of MerTK and
Protein S in the atheroma may act to reduce the overall severity of the disease. Together,
these studies provide unequivocal evidence of the importance of MerTK and
efferocytosis in atherosclerosis.

1.4 Fcγ receptor signal transduction as a putative model of
MerTK signalling
While little is known of the signalling of efferocytic receptors such as MerTK, it is likely
that they share some commonalities with other internalization pathways. Indeed,
phagocytic receptors face many of the same challenges as efferocytic receptors, such as
engagement and internalization of large particulate targets, and therefore represent good
models of putative efferocytic signalling pathways. Fcγ receptors (FcγR) are among the
best understood phagocytic receptors. These receptors recognize the Fc region of IgGclass antibodies, allowing for phagocytosis of antibody-opsonised pathogens 47. Three
classes of Fcγ receptors have been identified: FcγRI, FcγRII, FcγRIII, with each class
having multiple isoforms. For instance, FcγRI is a high affinity receptor that can bind to
monomeric IgG, it is encoded by three genes (FcγRIA, FcγRIB, and FcγRIC), and is
expressed in monocytes and macrophages 48. FcγRII is also encoded by three genes
(FcγRIIA, FcγRIIB, and FcγRIIC) but is a low affinity receptor. Like FcγRII, FcγRIII is a
low affinity receptor but is encoded by two genes (FcγRIIIA and FcγRIIIB) 48. Not all
Fcγ receptors are pro-phagocytic, with some such as FcγRIIB binding to IgG but
inhibiting particle internalization 49. While vastly different in structure and affinity, these
receptors share a common signalling pathway, with the FcγRI, FcγRIIA, and FcγRIIIA
mediating phagocytosis through Immunoreceptor Tyrosine-based Activation Motifs
(ITAM), and the inhibitory FcγRIIB negatively regulating this ITAM pathway via
Immunoreceptor Tyrosine-based Inhibition Motifs (ITIM) 48.
Phagocytosis by FcγRs is initiated by binding of antibody-coated particle by these
receptors, leading to clustering of the receptors. Signalling is initiated by phosphorylation
of two tyrosine residues in the ITAM motifs by members of the Src-family of kinases.
Phosphorylation of ITAMs provides binding sites for the SH2-containing kinase, Syk,
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which then mediates downstream signalling 16 (Figure 1). This pathway is central to
FcγR-mediated phagocytosis as indicated by severe phagocytic deficits in Syk -/- mice,
which are completely unable to internalize IgG-opsonised particles 50.
Phosphorylation and activation of Syk leads to recruitment of additional signalling
adaptor proteins to the FcγR complex. The transmembrane protein Linker of Activated Tcell (LAT) directly binds to activated Syk and its phosphorylation induces recruitment of
other adaptor proteins such as Grb2 and Gab2 to the complex 16. Gab2 activates the lipid
kinase, Phosphoinositide 3-Kinase (PI3K). CrkII, an adaptor protein, and Syk activates
the guanine nucleotide exchange factor, DOCK180, and Vav, respectively, which in turn
activates Rac1 (a small guanosine triphosphatase phosphatase) which enables actin
remodeling 16 (Figure 1). Lipids play an important role in FcγR-mediated phagocytosis.
PI3K quickly accumulates at the site of phagocytic cup and phosphorylates PI(4,5)P2
producing PI(3,4,5)P3 which accumulates in the phagocytic cup 16 (Figure 1). PI(3,4,5)P3
is required for macrophages to engulf large particles (greater than 3μm in diameter), but
is dispensable for the uptake of smaller particles 24,51. Importantly, the inhibitory Fcγ
receptor, FcγRIIB, functions by recruiting Src homology 2 domain-containing protein
tyrosine phosphatase to its ITIM domain. Intermixing of the inhibitory receptor with
engaged activating receptor delivers this ITIM-recruited phosphatase which then
antagonizes signalling through the activating receptor’s ITAM motifs by
dephosphorylating both the ITAMs and the Src-family kinases which act to
phosphorylate the ITAMs 16. This ITAM/FcγR signalling pathway appears to be utilized
by other phagocytic receptors 52,53, suggesting it may be a universal pathway used by all
receptors involved in large particle ingestion, making it an intriguing model for
elucidating the signalling of other phagocytosis-like receptors such as MerTK-mediated
efferocytosis.
Another important model of phagocytosis of relevance to the study of MerTK is the
integrin-mediated phagocytosis model. Integrins are heterodimeric, transmembrane
receptors comprising of an alpha and beta subunit 54,55. They regulate cell signalling, cell
cycle and shape, cell migration, and phagocytosis 56,57. Integrins act as receptors in both
phagocytosis and efferocytosis, although the signalling of these receptors has only been
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Figure 1: Core FcγR phagocytic signalling pathways.
The signalling pathway involves binding of the ligand-coated particle onto Fcγ receptor,
clustering of the receptors, leading to transmission of downstream signals, and particle
internalization by actin-driven process. The dashed arrow indicates indirect activation.
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explored in models of phagocytosis. Importantly to my thesis, the integrins αvβ3 and αvβ5
are likely involved in MerTK-mediated uptake of apoptotic cells, suggesting that MerTK
signalling must intercept the integrin-phagocytic pathway at some point 58,59.
Integrins can signal in two directions: inside-out signalling and outside-in signalling.
Inside-out signalling induces the high affinity state of integrins, and is driven by
intracellular signalling. Integrins in their inactive state are in a bent conformation that
masks their binding domain, creating a low affinity for their ligands. Inside-out signalling
occurs when the N-terminal domain of the cytoskeletal protein, talin, binds to the NPX
(Y/F) motif in β tail of the integrin, changing its conformation such that the binding site
is exposed leading to an increase in its affinity for its ligands 60. In addition, inside-out
signalling can increase the diffusion of integrins, allowing for integrin clustering, leading
to a concurrent increase in integrin avidity, and further enhancing integrin-ligand
interactions 60. Outside-in signalling occurs when the high-affinity integrin binds to its
ligand. Ligand binding to the extracellular domains of an active integrin recruits a
network of proteins, leading to local reorganization of actin cytoskeleton. Regulators of
the outside-in signalling pathways include focal adhesion kinase (FAK), Rho GTPbinding proteins, and adaptor proteins such as Cas, Crk, and paxillin 60. Both the outsidein and inside-out signalling pathways are required for integrin-mediated phagocytosis and
may be equally important for MerTK-mediated efferocytosis.
Complement receptor 3, also known as Mac-1 or αmβ2, was the first phagocytic integrin to
be characterized 16,60. Phagocytosis by αmβ2 requires external stimulatory signals such as
chemokines or bacterial products to activate Rap1 (a member of the Ras family of small
GTP-binding proteins). This leads to recruitment of talin to the β tail of αmβ2 leading to
its activation. Bacteria opsonised with complement C3bi binds to αmβ2 leading to
internalization of the bacteria by RhoA-dependent actin polymerization pathway 16,60.
Following ligation of αmβ2, RhoA is activated and recruited to the site of phagocytosis
where it activates the serine/threonine kinase, Rho-associated protein kinase (ROCK),
which then mediates recruitment of actin-related protein-2/3 and activation of myosin IIA
to drive actin polymerization and reorganization. There is evidence that mutation of the
β-integrin intracellular tail impedes RhoA activation and thus phagocytosis 56. In
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addition, αmβ2 appears to be able to activate the Src/Syk pathway utilized by Fcγ
receptors via the ITAM-bearing adaptor proteins, FcRγ and DAP12 61. This suggests that
a combination of ITAM signalling and RhoA is important for αmβ2- mediated
phagocytosis and therefore may be important for efferocytosis via the MerTK-integrin
pathway.
The integrins identified as being involved in clearance of apoptotic cells are not the same
as those involved in phagocytosis. Efferocytic integrins include αvβ3 and αvβ5 53,59. Like
MerTK, αvβ5 does not directly bind to phosphatidylserine on apoptotic cells but instead is
bridged by the opsonin, Milk Fat Globule-EGF factor 8 (MFG-E8), also known as
lactadherin (Figure 2). While αmβ2-mediated phagocytosis is dependent on RhoA, it is
unclear if RhoA plays a role in αvβ5 efferocytosis. Moreover, it has not been tested
whether the ITAM/Src/Syk pathway is utilized by any efferocytoic receptor. It is
established that αvβ5 efferocytosis is dependent on Rac1 activation 60, which occurs
downstream of ITAMs during FcγR-dependent phagocytosis. αvβ5 activates Rac1 by the
Dock180-ELMO complex (a cascade that involves p130Cas and CrkII pathway) and the
RhoA-related protein, RhoG, all processes thought to be downstream of Src-family
kinases and/or ITAMs 26,58. Critically, Wu et al. 58 revealed that neither MerTK nor αvβ5
integrin are independently sufficient for efferocytosis, but instead that efferocytosis
requires their combined activity. We believe this indicates that MerTK provides the
inside-out signal that induces the high affinity state of αvβ5, which then engages the
apoptotic cell and recruits the full internalization machinery to the forming efferocytic
cup through its outside-in signalling (Figure 2) – a possibility to be tested in our future
studies.
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Figure 2: Schematic of the known αvβ5 integrin and MerTK signalling pathway.
MerTK signalling pathway may intersect with αvβ5 integrin through activation of FAK by
Src-family kinases mediating the internalization of apoptotic cells.
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1.5 Hypothesis and objectives
The signalling pathway of MerTK in macrophages remains unknown, but because
efferocytosis results in a vastly different immunological outcome compared to
phagocytosis, I hypothesized that MerTK signals and engages integrins through a
novel signalling pathway different from that used by other phagocytic receptors. To
address this hypothesis, my initial objectives were to determine if common regulators of
phagocytosis/endocytosis regulate MerTK-mediated efferocytosis, and to use
phosphotyrosine immunoprecipitation followed by mass spectrometry to identify kinase
pathways activated by MerTK ligation. Once the proteins were identified and validated,
their signalling dynamics were to be assessed by confocal microscopy of fluorescentlytagged signalling molecules and through siRNA/pharmacological inhibition. Initially, I
also proposed to generate tagged and mutagenized variants of MerTK to use in the
signalling and immunoprecipitation studies. Lastly, I had planned on comparing the
activity of the identified signalling pathways under normal and atherosclerotic conditions
thereby identify any defects in MerTK signalling that may account for its role in
atherosclerosis.
However, due to difficulties in identifying a cell line with consistent MerTK expression
and in generating an ectopic expression model, the project proposal had to be modified.
Instead, in my first objective I characterized the expression of endogenous MerTK in
primary human macrophages. In my second objective, MerTK endocytosis was induced
in M0 primary human macrophages by antibody-crosslinking, and the role of the
common phagocytic regulators Src-family kinases, Syk and PI3K in MerTK endocytosis
were assessed using pharmacological inhibitors. Thirdly, the role of these signalling
pathways was assessed in the induction of MerTK-dependent tyrosine phosphorylation.
In the final objective, I sought to immunoprecipitate proteins tyrosine-phosphorylated by
MerTK crosslinking, with the goal of identifying these signalling regulators using an
unbiased mass spectrometry approach.
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Chapter 2: Materials and methods
2.1 Murine macrophage cell culture
RAW264.7 and J774.1 murine macrophages were cultured in RPMI-1640 (Wisent)
containing 10% Fetal Bovine Serum (Invitrogen). ANA-1 murine macrophages were
cultured in Dulbecco's Modiﬁed Eagle's Medium (Wisent) supplemented with 10% FBS.
All cells were cultured at 37°C in 5% CO2 and split at 80% confluency. RAW264.7 and
J774.1 cells were a gift from S. Grinstein, Hospital for Sick Children, and ANA-1 cells
were a gift from M. Valvano, Western University.

2.2 Primary human macrophage cell culture
Blood collection was approved by Western University’s Health Sciences Research Ethic
Board and complies with the Tri-Council Policy Statement on human research. Human
blood was drawn from healthy consenting donors using butterfly blood collection needles
and 10mL BD Vacutainer sodium heparin tubes (Thermo Fisher). Blood was layered in
15mL Falcon tubes over an equal volume of Lympholyte-poly cell separation media
(Cedarlane), followed by centrifugation at 500 x g for 35 minutes with no brake, and
removal of the top band of cells, the peripheral blood mononuclear cells (PBMCs).
PBMCs were washed with room-temperature phosphate-buffered saline (PBS) at 300 x g
for 6 minutes, diluted with RPMI-1640 containing 10% FBS and antibiotic antimycotic
solution (Corning), then plated on 12-well plates with 18mm coverslips placed in the
wells or on 6-well plates coated with 0.1% gelatin solution. Cells were incubated at 37°C
under 5% CO2 for 1 hour to allow selective adherence of the PBMCs.
After 1 hour, cells were washed with warm PBS to remove non-adherent cells followed
by addition of RPMI-1640 containing 10% FBS, antibiotic antimycotic solution (100X),
and differentiated with cytokines (1000X) from R&D Systems: 10ng/mL recombinant
human (rh) M-CSF (to obtain M0 & M2) or 20ng/mL rhGM-CSF (to obtain M1),
differentiation for 5 days, followed by an additional 2 days of culture with 10ng/mL rhMCSF (for M0), 20ng/mL rhGM-CSF + 250μg/mL LPS + 100ng/mL IFN-γ (for M1) or
10ng/mL rhM-CSF + 10μg/mL IL-4 (for M2).
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2.3 Cloning human MerTK-wild type, mouse MerTK-wild
type and GFP, and human HA-MerTK
Human and mouse MerTK cDNA was purchased from the MGC genome collection. PCR
was used to amplify MerTK using Phusion High-Fidelity DNA Polymerase (Thermo
Scientific) with 35 cycles. Amplification primers were designed with SnapGene software
and are listed in Table 1 and 2. PCR products were purified using EZNA Cycle Pure Kit
(Omega Biotek). The amplified PCR products and target vectors were digested with their
corresponding restriction enzymes (Fermentas), as shown in Table 1 and 2, for 2 hours at
37ºC, purified using Geneclean II EZ-Glassmilk Kit (MP Biomedicals), and then ligated
overnight at 16°C using T4 DNA ligase (Fermentas). DNA sequencing was performed by
the London Genomics Centre (Robarts Research Institute, London, Canada). Plasmid
maps are located in the appendix (Figure A1).
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Table 1: Primers for cloning human MerTK-WT, mouse MerTK-WT, and mouse
MerTK-GFP
Insert

Amplification primer sequence (5’ to 3’)

Restriction

Target

name

with restriction sites underlined

Enzyme

vector

Human

FWD: AAA AAA GAA TTC ATG GGG

EcoRI

MerTK- CCG GCC C
pEGFP-

WT
REV: AAA AAA ACC GGT TCA CAT
CAG GAC TTC TGA GCC TTC T
Mouse

FWD: AAA AAA GAA TTC ATG GTT

N1
AgeI

EcoRI

MerTK- CTG GCC CCA CTG
pEGFP-

WT
REV: AAA AAA ACC GGT TCA CAT
CAG AAC TTC AGA GTC TTC CAA GG
Mouse

N1
AgeI

FWD: TAT GAA TTC ATG GTT CTG GCC EcoRI

MerTK- CCA CTG CTA CTG
pEGFP-

GFP
REV: GGT GGC GAC CGG TTT CAT
CAG AAC TTC AGA GTC TTC CA AGG
AGT

N1
AgeI
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Table 2: Primers for cloning human HA-MerTK
Amplification primer sequence (5’ to

Restriction

Target

3’) with restriction sites underlined

Enzyme

vector

Upstream

FWD: TTT TTT AGA TCT GCT ATC

BglII

half of HA-

ACT GAG GCA AGG GAA GAA

Insert name

pDisplay-

MerTK
REV: GAA GAG GGG GCA TAG
TCG ACC CAA CCG TGT GCA GGG

LAP2
SalI

ATA AAT
Downstream

FWD: ATT TAT CCC TGC ACA

half of HA-

CGG TTG GGT CGA CTA TGC CCC

MerTK

CTC TTC
REV: TTT TTT CTC GAG TCA CAT

SalI
pBluescript
XhoI

CAG GAC TTC TGA GCC TTC TGA
Full-length

FWD: TTT TTT AGA TCT GCT ATC

HA-MerTK

ACT GAG GCA AGG GAA GAA

BglII
pDisplay-

REV: TTT TTT CTC GAG TCA CAT
CAG GAC TTC TGA GCC TTC TGA

LAP2
XhoI
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Table 3: Antibodies with dilutions and sources
Antibody

Dilution

Source

Rabbit monoclonal anti-

1:1000

Abcam

Donkey anti-rabbit IR-700

1:10,000

Jackson ImmunoResearch

Rabbit monoclonal anti-

1:1000, 1:500, 1:200

Abcam

1:1000

Jackson ImmunoResearch

1:1000

Jackson ImmunoResearch

Goat anti-human 488 Fab

1:1000

Jackson ImunoResearch

F(ab’)2 goat anti-rabbit

1:200

Jackson ImmunoResearch

1:1000

Jackson ImmunoResearch

1:500

Jackson ImmunoResearch

1:1000

Millipore

mouse MerTK antibody

human MerTK
Dylight 488-conjugated
Fab fragment donkey antirabbit IgG
Cy3-conjugated Fab
fragment donkey antirabbit IgG

IgG Fc fragment specific
Dylight 488-conjugated
Fab anti-mouse
Goat anti-rabbit Cy3conjugated F(ab’)2
Mouse monoclonal antiphosphotyrosine, clone
4G10
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2.4 Immunoblotting for endogenous MerTK on RAW264.7
and J774.1 cells
RAW264.7 and J774.1 cells were plated at approximately 5 x 105 cells per 35mmdiameter well and were incubated for 24 hours to obtain approximately 80% confluency.
Cells were lysed with 4X Laemmli buffer containing 1/10th volume of β-mercaptoethanol,
and protease plus phosphatase inhibitors (100X, Thermo Scientific). Cell lysates were
vortexed for 30 seconds, boiled at 100°C for 5 minutes, and ran on a 12% SDS-PAGE for
one hour at 110V. Protein bands were transferred onto a nitrocellulose membrane for two
hours at 85V, then membrane was blocked with Tris-Buffered Saline with Tween (TBST)
plus 5% Bovine Serum Albumin (BSA) for 4 hours. The membrane was probed with
rabbit monoclonal anti-mouse MerTK antibody (1:1000, Abcam) for 2 hours and donkey
anti-rabbit IR-700 (1:10,000, Jackson ImmunoResearch) for 1 hour. Three-15 minutes
washes with TBST followed each antibody incubation step. The membrane was imaged
with LI-COR Odyssey Infrared Imaging System.

2.5 Immunostaining for MerTK expression
J774.1 and ANA-1 macrophages were plated at approximately 5 x 105 cells per 18mm
coverslip on a 12-well plate and were incubated for 24 hours to obtain approximately
80% confluency, while primary human macrophages were cultured onto 12-well plates
with coverslip as per “Primary human macrophage cell culture” protocol (Section 2.2).
Cells were fixed with 4% PFA at room temperature for 20 minutes then blocked with 1%
BSA at room temperature for 30 minutes. Primary human macrophages were
immuostained with DAPI (1:1000, Abnova) and rabbit monoclonal anti-human MerTK
(1:1000, Abcam) while J774.1 and ANA-1 macrophages were stained with DAPI and
rabbit monoclonal anti-mouse MerTK for 1 hour, followed by Dylight 488-conjugated
Fab fragment donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch) and Cy3conjugated Fab fragment donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch),
respectively. Cells were mounted with PermaFluor and images were acquired using
Olympus IX70 inverted fluorescent microscope equipped with a 60X/0.9NA objective
and operated by micro-manager software 63, or imaged on a Zeiss LSM510 meta confocal
microscope equipped with a 60X/1.0NA objective.
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2.6 Co-transfection of HeLa and RAW264.7 cells with
pIRES2-EGFP MerTK and mCherry-Rab7
Cells were seeded onto 18mm coverslips placed into the wells of a 12-well plate and
incubated for 24 hours at 37°C to obtain approximately 80% confluency. The media on
the cells was replaced with fresh media one hour prior to transfection. RAW and HeLa
cells were transfected with 1.1μg of each plasmid using FuGENE-HD transfection
reagent (Promega). After 24 hours of transfection, the cells were fixed with 4% PFA and
mounted with PermaFluor (Thermo Scientific). The pIRES2-EGFP murine MerTK
plasmid was purchased from Addgene (#14998). Plasmid map is located in the appendix
(Figure A1). Images were captured using Olympus IX70 inverted fluorescent microscope
equipped with a 60X/0.9NA objective and operated by micro-manager software 63.

2.7 Phagocytosis assay of M0 primary human
macrophages
M0 primary human macrophages were cultured onto a 12-well plate as per “Primary
human macrophage cell culture” protocol (Section 2.2). 4.95μm Protein A-coated beads
and 5.09μm polystyrene microsphere beads (Bangs Laboratories) were used as
phagocytic targets.
Protein A-coated beads were prepared by diluting 10μL of beads with 500μL of 1X PBS.
For anti-human MerTK-coated beads, 10μL of the diluted beads was mixed with 2.5μL of
rabbit monoclonal anti-human MerTK antibody. For isotype control beads, 10μL of the
diluted beads was mixed with 2.5μL of whole human IgG. Beads were rotated for 30
minutes at room temperature, washed with 1mL of 1X PBS, and stained with eFluor 670
Cell Proliferation Dye (1:1000, eBioscience). Beads were washed, re-suspended with
1mL of HEPES RPMI, and added into each well of macrophages. Macrophages were
centrifuged at 500 x g for 1 minute then phagocytosis was induced by incubating them at
37ºC for 30 minutes. After incubation, cells were washed with 1X PBS then noninternalized beads were labelled with anti-rabbit 488 Fab, or goat anti-human 488 Fab
(Jackson ImmunoResearch) for isotype control. Cells were fixed with 4% PFA for 20
minutes at room temperature, immunostained for MerTK and counterstained with DAPI
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as per immunostaining protocol (Section 2.5). After mounting with Permaflour (Thermo
Scientific), images were acquired with 60X objective using Olympus IX70 inverted
fluorescent microscope.
Polystyrene microsphere beads were prepared by mixing 10μL of the beads with 500μL
of PBS, and 2.5μL of F(ab’)2 goat anti-rabbit IgG Fc fragment specific antibody (Jackson
ImmunoResearch) then rotating for 15 minutes at room temperature. Beads were washed
three times with 1X PBS and blocked with 500μL of 5% BSA for 15 minutes, washed
thrice again, and then 10μL of beads were re-suspended with 500μL of 1X PBS and
rabbit monoclonal anti-human MerTK antibody (1:200, Abcam) or rabbit anti-sheep Far
Red for the isotype control. Beads were rotated for 1 hour then washed thrice. Antihuman MerTK beads were labelled with eFluor 670 Cell Proliferation Dye (1:1000,
eBioscience). Beads were re-suspended with 1mL of HEPES RPMI. Phagocytosis was
induced by adding the 1mL of bead-containing HEPES RPMI into each well of
macrophages, centrifuging at 500 x g for 1 minute, and incubating plates at 37°C for 30
minutes. Unbound beads were removed by three washes with 1X PBS then noninternalized external beads were labelled with Dylight 488-conjugated Fab fragment
donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch) for 20 minutes. Cells were
washed, fixed with 4% PFA for 20 minutes at room temperature, and mounted with
Permaflour. Images were acquired with 60X objective using DIC and Olympus IX70
inverted fluorescent microscope.

2.8 Induction of IgG-mediated phagocytosis by RAW264.7
cells
RAW264.7 macrophages were plated at approximately 5 x 105 cells per 18mm coverslip
on a 12-well plate and were incubated for 24 hours to obtain approximately 80%
confluency. Whole mouse IgG-coated beads were prepared by mixing 10μL of 5.09μm
polystyrene microsphere beads (Bangs Laboratories) with 300μL of 1X PBS and 15μL
whole mouse IgG then rotating for 1 hour at room temperature. Beads were washed twice
and re-suspended with 500μL of 1X PBS then 10μL of coated beads was added to each
well of macrophages in 1mL of serum-free HEPES RPMI. The cells were centrifuged at
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500 x g for 1 minute then incubated at 37°C for 30 minutes. Unbound beads were
removed by two washes with room temperature 1X PBS and non-internalized external
beads labelled with anti-mouse Dylight 488 antibody (1:1000; Jackson ImmunoResearch)
for 20 minutes. Cells were washed twice, fixed with 4% PFA for 20 minutes at room
temperature, and mounted with Permaflour. For inhibition of IgG-mediated phagocytosis,
the cells were treated with 50μM LY294002, 50μM piceatannol, and 30μM PP1 for the
duration of the experiment. Images were acquired with 60X objective using DIC and
Olympus IX70 inverted fluorescent microscope. Phagocytic index was calculated by
dividing the total number of internalized beads by total number of macrophages counted.
A minimum of 45 macrophages were counted for each condition (untreated, LY294002,
piceatannol, and PP1-treated) in one experiment. Images were analyzed on Fiji ImageJ
software (http://fiji.sc/Fiji). Graph was created using GraphPad Prism.

2.9 MerTK endocytosis assay
M0 primary human macrophages were cultured onto 18mm coverslips on a 12-well plate
as per “Primary human macrophage cell culture” protocol (Section 2.2). Basal levels of
endocytosis was inhibited by pre-incubating cells for 4 hours prior to the experiment in
serum-free RPMI-1640, and the cells were cooled to 10°C prior to MerTK crosslinking.
MerTK was ligated by the addition of rabbit anti-human MerTK (1:500, Abcam) for 20
minutes at 10°C, followed by three washes in 1X PBS, and then crosslinked with goat
anti-rabbit Cy3-tagged F(ab’)2 (1:500, Jackson ImmunoReaserch). The cells were washed
with 37°C RPMI with HEPES and incubated at 37°C for 20 minutes to allow for MerTK
internalization. Internalization was stopped by washing the cells with 10°C 1X PBS, and
surface-bound antibody was removed by 2 minutes acid-wash (1X PBS, pH 2.0 10°C).
Cells were fixed for 20 minutes with 4% PFA at 10°C, co-stained with wheat-germ
agglutinin (1:1000) for 5 minutes at 10°C, and then mounted with Permaflour (Thermo
Scientific). A sufficient number of fields (4-5 fields, 10 cells/field) were imaged before
and after acid washing to ensure a statistically representative sample of MerTK
expression and internalization. Images were acquired using Olympus IX70 inverted
fluorescent microscope equipped with a 60X/0.9NA objective and operated by micromanager software 63.
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For pharmacological inhibition studies, macrophages were incubated with the PI3K
inhibitor LY294002 at 50μM, the Syk inhibitor piceatannol at 50μM, and the Src-family
kinase inhibitor PP1 (Tocris Bioscience) at 30μM from 10 minutes prior to internalization
until fixation.

2.10 Phosphotyrosine immunostaining
M0 primary human macrophages were cultured as per “Primary human macrophage cell
culture” protocol (Section 2.2). Cells were serum starved for 4 hours to reduce basal
phosphoprotein levels then cooled at 10°C for 15 minutes. For pharmacological
inhibition studies, macrophages were incubated with the PI3K inhibitor LY294002 at
50μM, the Syk inhibitor piceatannol at 50μM, and the Src-family kinase inhibitor PP1 at
30μM, with inhibitors added 20 minutes prior to stimulation and kept on the sample until
fixation. Rabbit monoclonal anti-human MerTK (1:500, Abcam) was added to the cells
for 20 minutes at 4°C, the cells were washed three times with 4°C 1X PBS then treated
with crosslinking goat anti-rabbit Cy3-tagged F(ab’)2 (1:500, Jackson ImmunoResearch).
Cells were incubated at 4°C for 20 minutes then fixed with 4% PFA for 20 minutes at
room temperature. Cells were blocked and permeabilized with 1X PBS + 0.1% Triton X100 + 5% rat serum for 1 hour at room temperature followed by incubation with mouse
monoclonal anti-phosphotyrosine antibody, clone 4G10 (1:1000, Millipore) in blocking
buffer overnight at 4°C. Cells were immunostained with donkey anti-mouse 488-tagged
Fab secondary antibody (1:1000, Jackson ImmunoResearch) for 1 hour at room
temperature. Images were acquired using Olympus IX70 inverted fluorescent microscope
equipped with a 60X/0.9NA objective and operated by micro-manager software 63.

2.11 Phosphotyrosine immunoblotting
ANA-1 macrophages were plated onto 35mm-diameter well and incubated for 24 hours
to obtain approximately 80% confluency. Cells were serum starved with serum-free
DMEM for 4 hours under 37°C, 5% CO2 incubation. 10μL of Protein G beads (Pierce)
was washed once with 1X PBS, suspended in 100μL of 1X PBS, and then 3μL of rabbit
monoclonal anti-mouse MerTK or 10μL of whole mouse IgG for isotype control was
added to the beads. Beads were rotated for 30 minutes at room temperature, washed twice
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with 1X PBS, and re-suspended in 3mL of 10°C serum-free DMEM. After 4 hours of
serum-starvation, the cells were cooled with 10°C serum-free DMEM for 15 minutes then
2mL of 10°C bead media was added to the cells. Cells were spun at 300 x g for 1 minute
at 10°C and incubated at 10°C for 20 minutes. Cells were lysed with 4X Laemmeli buffer
containing 1/10th volume of β-mercaptoethanol and protease and phosphatase inhibitors
(100X), vortexed for 30 seconds, boiled at 100°C for 5 minutes, and ran on 12% SDSPAGE. Protein bands were transferred to a nitrocellulose membrane and membrane was
blocked with TBST plus 5% BSA for 4 hours. The membrane was probed with mouse
monoclonal anti-phosphotyrosine antibody, clone 4G10 (1:1000; Millipore) for 2 hours
and anti-mouse IR-700 (1:10,000) for 1 hour. Three-15 minutes washes with TBST
followed each antibody incubation step. The membrane was imaged with LI-COR
Odyssey Infrared Imaging System.
M0 primary human macrophages were cultured on 6-well plates with coverslips
following “Primary human macrophage cell culture” protocol. The cells were serumstarved with serum-free RPMI for 4 hours prior to the experiment. Unstimulated cells
were left on ice in serum-free HEPES RPMI while EGTA-treated cells were treated with
PEG media (0.045g of sucrose, 0.019g of 5mM EGTA, and 10μL of 1X PBS) for 10
minutes on ice. To stimulate cells with IgG immune complex, whole human IgG was
heated at 62°C for 20 minutes, spun at 16,000 x g for 10 minutes, and then the
supernatant was added to the cells (1:40 dilution in HEPES RPMI). The cells were
incubated at 37°C for 30 minutes and washed with ice-cold 1X PBS. MerTK was
activated by treating the cells with 1:1000 rabbit monoclonal anti-human MerTK
antibody (Abcam) for 20 minutes on ice, then crosslinking with goat anti-rabbit Cy3tagged F(ab’)2 (1:1000, Jackson ImmunoResearch) for 20 minutes on ice. Cells were
incubated on ice for an additional 20 minutes to enhance tyrosine phosphorylation then
lysed with 4X Laemmeli buffer containing 1/10th volume of β-mercaptoethanol and
protease and phosphatase inhibitors (100X). Cell lysate was ran on 12% SDS-PAGE and
transferred to nitrocellulose membrane. The membrane was blocked with 5% BSA for 4
hours, probed with mouse monoclonal anti-phosphotyrosine antibody, clone 4G10
(1:1000; Millipore) for 2 hours and anti-mouse IR-700 (1:10,000, Jackson
ImmunoResearch) for 1 hour. For loading control, the membrane was probed with mouse
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anti-actin antibody (1:500, Developmental Studies Hybridoma Bank) and anti-mouse IR800. Three-15 minutes washes with TBST followed each antibody incubation step. The
membrane was imaged with LI-COR Odyssey Infrared Imaging System.

2.12 Phosphotyrosine immunoprecipitation
M0 primary macrophages were cultured on a one-well plate coated with 0.1% gelatin as
per “Primary human macrophage cell culture” protocol (Section 2.2). Cells were serumstarved with serum-free RPMI for 4 hours prior to the experiment. Unstimulated cells
were left on ice in serum-free HEPES RPMI while MerTK activated cells were treated
with rabbit monoclonal anti-human MerTK at a dilution of 1:500 for 20 minutes on ice
followed by goat anti-rabbit Cy3-tagged F(ab’)2 secondary antibody (1:500) for 20
minutes on ice. Cells were incubated for additional 20 minutes then lysed with 1mL of
lysis buffer containing wash buffer (20mM Tris-HCl pH 8.0, 0.15M NaCl, 2mM EDTA,
1% Nonidet P-40, 10% glycerol, 1mM Na3VO4), 0.25mM phenylmethylsulfonyl fluoride,
200nM Okadaic acid, 10mM NaF, and protease and phosphatase inhibitor (100X). The
cell lysate was rotated at 4°C for 40 minutes then spun at maximum speed for 15 minutes.
The supernatant was recovered and 50μL was kept for lysate controls while 40μL of antiphosphotyrosine antibody, clone 4G10, agarose conjugate (EMD Millpore) was added to
the remainder of the supernatant. The supernatant was incubated at 4°C rotating for 16
hours.
After the 16-hours incubation, the slurry was washed five times with wash buffer
followed by elution with 70μL of 1X phenyl phosphate, disodium salt dehydrate (Fisher
Scientific) at 4°C for 30 minutes. The slurry was spun at 4°C at maximum speed for 15
minutes and the immunoprecipitate recovered. A one-quarter volume of 4X Laemmli
buffer with 50mM DTT was added to the immunoprecipitate and 0.5% total cell lysate
samples, which were then boiled for 2 minutes at 100°C, and ran on a 10% SDS-PAGE at
100V for 2 hours. The gel was fixed with 40% ethanol + 10% acetic acid for 15 minutes,
and stained with BioRad QC colloidal coomassie stain for 20 hours. The gel was
destained with deionized water for 3 hours then imaged on Gel Doc EZ Imager from
BioRad.
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2.13 Quantification of mean fluorescence intensity and colocalization
Mean Fluorescence Intensity (MFI) was measured by tracing the area occupied by cells
on Fiji ImageJ software while taking background measurement for each cell. Twenty
cells per condition for each experiment were analyzed. Corrected means were calculated
on Microsoft Excel spreadsheet by subtracting the means from the background
measurements, then MFI graph was created using GraphPad Prism software.
Pearson’s correlation coefficient was calculated on Fiji ImageJ software using Just
Another Co-localization Plugin 64. Thresholds values were set for 4G10 and MerTK
images. R values calculated by the plugin were imported into Microsoft Excel
spreadsheet which was used to calculate average R values for each group in each
experiment. Calculation of standard error of the mean (SEM), graphs and statistics were
then created using GraphPad Prism software.

2.14 Statistical analysis
One-tailed Student’s t-tests or ANOVA using Bonferroni method were performed as
appropriate using GraphPad Prism software. Data are presented as mean + SEM.
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Chapter 3: Results
3.1 Murine macrophage cell lines lack consistent MerTK
expression
Cell lines consistently expressing endogenous MerTK were required for my research.
Therefore, I quantified MerTK expression using western blotting of the commonly used
murine macrophage cell lines, RAW647.2 (RAW) and J774.1 65–67. The first western blot
did not show protein band corresponding to MerTK for RAW cells but, consistent with
reports in the literature 68, showed a faint band between 100-150 kDa corresponding to
MerTK for J774.1 cells as indicated by the red arrow (Figure 3A). The same culture of
cells displayed a plasmalamellar (ring-like) distribution of MerTK on J774.1 cell surface
by confocal microscopy (Figure 3B), consistent with the J774.1 cell line expressing
MerTK. However, it was not possible to consistently reproduce these results in J774.1
cells. Subsequent immunoblots either lacked any protein bands or displayed only nonspecific antibody binding to proteins of the incorrect molecular mass, while subsequent
microscopy experiments observed a small percentage (less than 5%) of J774.1 cells
showing a weak plasmalamellar staining pattern with the bulk of the cells in the samples
showing no staining (data not shown). Several alternate primary antibodies and cell
culture conditions were tested, but none of these produced consistent and clear MerTK
expression, thereby eliminating J774.1 cells as a viable model system.
The less commonly used ANA-1 murine macrophage cell line was then tested for
endogenous MerTK expression. Both conventional immunofluorescence images (Figure
3C) and confocal microscope images (Figure 3D) revealed non-specific background
fluorescence instead of the expected plasmalamellar staining indicative of MerTK
expression. Since microscopy has limited sensitivity, I indirectly tested for MerTK
expression by adding MerTK antibody-conjugated beads, followed by phosphotyrosine
immunoblotting to detect any resulting MerTK signalling. This method was used because
it has been shown that receptor activation leads to phosphorylation of downstream
proteins detectable by immunoblotting 19. The resulting immunoblot revealed only basal
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Figure 3: Murine macrophage cell lines lack consistent MerTK expression.
A) Western blotting performed on RAW264.7 and J774.1 cell lysates revealed MerTK
protein band only in J774.1 (red arrow). This blot represents the one experiment, out of
five, which showed MerTK protein band. B) Fluorescent microscopy of endogenous
MerTK expression on J774.1 macrophages using confocal microscopy. The image is
representative of ten images captured in one experiment. Scale bar is 10 μm. C)
Widefield microscopy image of ANA-1 macrophages immunostained with anti-mouse
MerTK (red) and counterstained with DAPI (blue). Image is representative of three
independent experiments. Scale bar is 10μm. D) Confocal Z-stack image of ANA-1
macrophage stained with anti-mouse MerTK (red). Image is representative of three
images captured in one experiment. E) Phosphotyrosine (4G10) immunoblot of either
20μL or 40μL of ANA-1 cell lysates from non-crosslinked (Iso) or MerTK (Mer)
crosslinked cells. The blot is representative of two experiments.
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levels of phosphorylation in the MerTK crosslinked lane (Figure 3E). The lack of
increased phosphorylation in stimulated ANA-1 cells combined with the
immunofluorescence results confirms that these cells do not express endogenous MerTK.
Therefore, none of the tested murine macrophage cell lines were viable models for
MerTK analysis.

3.2 Generating MerTK ectopic expression system
The lack of consistent MerTK expression on murine macrophage cell lines necessitated
the generation of macrophages stably expressing ectopic MerTK. I tried several methods
to clone full-length MerTK for instance, conventional cloning of wild-type human and
murine MerTK, and murine GFP-tagged MerTK into the mammalian expression vector,
pEGFP-N1 (Table 1, appendix Figure A1). However, screening for positive clones by
restriction enzyme digestion revealed either empty vectors or inserts only a few hundred
base-pairs in size (data not shown), rather than the expected 3 kb full-length MerTK
amplicon produced by PCR.
Since conventional cloning methods were unsuccessful, a different approach was carried
out, as highlighted in Figure 4A, to generate HA-tagged human MerTK. A SalI site was
inserted into the middle of MerTK by site-directed mutagenesis in fashion that does not
introduce a change in the amino acid sequence (Figure 4A). A BglII site was inserted
upstream of the gene and an XhoI site downstream (Table 2). The 5’ (BglII to SalI)
fragment of MerTK was amplified by PCR and cloned into the HA-containing pDisplayLAP2 vector, while the 3’ fragment (SalI to XhoI) was to be cloned into pBluescript.
Cloning of both fragments was determined to be successful by colony PCR and DNA
sequencing (data not shown), after which the 3’ MerTK fragment was excised from
pBluescript and ligated into the 5’ pDisplay-LAP2 vector digested with SalI and XhoI.
The transformation of this construct led to recovery of only a small number of clones.
Colony PCR of the resulting constructs revealed a 3 kb band believed to be full-length
MerTK (red box, Figure 4B). However, when sequenced, only MerTK constructs
containing point mutations, insertion and deletions, or frame-shift mutations were
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Figure 4: Generating HA-tagged human MerTK ectopic expression system.
A) SnapGene schematic of one of several strategies used to attempt cloning HA-tagged
human MerTK into pDisplay-LAP2. B) Colony PCR gel of full-length MerTK cloned
into pDisplay-LAP2. Colony 2 (red square) appears to be a full-length (3 kb) MerTK
clone. C) Alignment comparing human MerTK with the sequence of colony 2 (C2) from
panel B. Point mutations are highlighted in green, frame-shift mutation is highlighted in
red, and a stop codon arising due to the frame-shift mutation is highlighted in cyan.
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recovered. An example of this is shown in Figure 4C, where the alignment of a recovered
MerTK clone with the reference human MerTK sequence shows both point mutations and
a frame-shift mutation (highlighted in green and red, respectively). The frame-shift
mutation creates a premature stop codon within the reading frame (cyan highlight, Figure
4C) producing a truncated protein lacking the transmembrane and intracellular kinase
domains. The failure of our earlier cloning attempts and this sequencing result is
consistent with this gene being somehow toxic to the bacteria used for cloning, perhaps
due to low-level expression resulting in cytosolic expression and aggregate formation of a
normally transmembrane protein. Thus, this toxicity would lead to recovery of only rare
mutated sequences such as those illustrated in Figure 4C which eliminate the portions of
the MerTK gene causing toxicity in the cloning bacteria.

3.3 pIRES2-EGFP murine MerTK is not expressed in
transfected HeLa and RAW264.7 cells
During our attempts at cloning MerTK, a murine MerTK plasmid with MerTK under
control of a mammalian promoter plus a downstream pIRES2-EGFP became available
from Addgene (appendix Figure A1). I attempted to use this construct to make a stable
MerTK expressing cell line that could then be used for studying MerTK signalling
pathway. HeLa and RAW cells were co-transfected with this construct, plus a mCherry
(example, mCherry-Rab7) expressing plasmid as a positive control for transfection. The
images revealed high rates of transfection, as indicated by high levels of mCherry
expression in a large proportion of both HeLa (>70% transfection) and RAW cells (>30%
transfection, Figure 5, top images). However, the mCherry positive cells lacked GFP
expression (Figure 5, bottom images), and thus lacked MerTK expression. Several
different transfection ratios of MerTK:mCherry were tested with none producing
measurable MerTK/GFP expression (data not shown). It is unclear why we did not
observe MerTK/GFP expression in these cells, as sequencing of the plasmid revealed the
expected sequence of MerTK and there were no signs of toxicity in the transfected cells.
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Figure 5: pIRES2-EGFP murine MerTK is not expressed in transfected HeLa or
RAW264.7 cells.
HeLa and RAW264.7 cells were co-transfected with mCherry-Rab7 (top images) and
pIRES2-EGFP murine MerTK plasmid (bottom images). Images were taken through 60X
objective on an inverted fluorescence microscope and are representative of three separate
experiments. Scale bar is 10 μm.
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3.4 MerTK is expressed in M0 and M2 primary human
macrophages
Since none of the tested murine cell lines expressed MerTK and our attempts at cloning
and expressing recombinant MerTK had failed, I altered my approach in order to use
primary human cells expressing endogenous MerTK. This required identification of a
phagocytic cell type that expressed MerTK under normal conditions. Therefore, I tested
primary human macrophages differentiated into M0 (unpolarized), M1, or M2 subtypes
and analysed them for endogenous MerTK expression.
M0 and M2 macrophages exhibited a pattern of MerTK expression characteristic of a
plasma membrane localized protein, while M1 macrophages displayed mostly nonspecific background fluorescence (Figure 6A). Quantification of these images revealed
that 88 percent of M0 macrophages were MerTK positive, 93 percent of M2 were MerTK
positive, while only 18 percent of M1 were MerTK positive (Figure 6B). When MerTK
expression levels were quantified, the small portion of MerTK positive M1 cells
expressed significantly less MerTK than M0 or M2 cells, while M0 and M2 cells
expressed equivalent amounts of MerTK (Figure 6C). This led to the conclusion that
MerTK is expressed on primary human macrophages of the M0 and M2 lineages. I chose
to use M0 macrophages for all subsequent experiments as these macrophages are the least
differentiated and are capable of further differentiation, thereby increasing the likelihood
that results observed in these macrophages will be consistent between multiple subtypes
of macrophages and will provide the opportunity to assess the impact of MerTK
signalling in mediating further macrophage differentiation.
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Figure 6: MerTK is expressed in M0 and M2 primary human macrophages.
A) M0, M1, and M2 macrophages were labelled with rabbit anti-human MerTK plus
Dylight 488-tagged Fab (green) and DAPI (blue). Images were captured through 60X
objective and are representative fields from two different experiments. Scale bar is 10
μm. B) Percentage of MerTK positive cells. Asterisks indicate statistically significant
difference (P < 0.05) compared with M1 macrophages using ANOVA with Bonferonni
correction. C) MerTK expression levels in mean fluorescence intensity. n.s. indicates
non-significant difference between M0 and M2, and asterisk indicates significant
difference compared to both M0 and M2 using ANOVA with Bonferonni correction.
Twenty cells per condition per experiment were analysed. Data are shown as mean +
SEM.
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3.5 Measuring MerTK-dependent efferocytosis by M0
primary human macrophages
After it was established that MerTK is expressed on M0 macrophages, MerTK’s
efferocytic ability was assessed using antibody-coated beads that were expected to
selectively engage MerTK, but not other efferocytic or phagocytic receptors. Different
methods were used to generate these beads, with all methods aimed at masking the Fc
region of the anti-MerTK antibody in order to avoid engagement of Fcγ receptors
(methods used to produce the different beads is described in section 2.7). All of the
various anti-MerTK-coated beads were readily internalized as indicated by the white
arrows (Figures 7A left image; Figure 7B top panels).
Unfortunately, in all cases, isotype antibody-coated beads (negative controls) were
internalized equally well (Figures 7A right image; Figure 7B bottom panels, white
arrows), indicating that our bead preparation methods were unable to mask the Fc region
of the anti-MerTK antibody, thus leading to internalization at least partially by FcγRmediated phagocytosis. Therefore, MerTK-specific efferocytosis by M0 macrophages
was not achieved, requiring that we improve the specificity of our bead model. This work
is currently being pursued by other members of our laboratory.

3.6 Crosslinking MerTK on M0 primary human
macrophages induces endocytosis independent of
Src/Syk and PI3-kinase
It is well established that crosslinking of phagocytic receptors induces the same signalling
and internalization pathways as do particulate targets engaging the same receptor 69.
Since our bead-based efferocytic assays were non-specific, we took advantage of this
phenomenon and used MerTK-crosslinking to selectively stimulate MerTK on M0
primary human macrophages. MerTK was crosslinked through addition of the antiMerTK antibody which was then either crosslinked by the addition of a Cy3-labelled
dimeric secondary F(ab’)2. Endocytosis was quantified by first imaging total MerTK on
the cells using widefield fluorescence microscopy, followed by an acid-wash to dissociate
antibodies from non-internalized MerTK, and then the cells were re-imaged to detect the
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Figure 7: Measuring MerTK-dependent efferocytosis by M0 primary human
macrophages.
A) Efferocytosis analysis of anti-human MerTK-coated Protein A beads (left image) and
whole human IgG (isotype control)-coated Protein A beads (right image). Images are
representative of two experiments. B) Efferocytosis assay of polystyrene beads coated
with anti-human MerTK then labelled with eFluor 670 (top images). Bottom images
show isotype control beads. Cells were imaged through 60X objective using a widefield
fluorescent microscope. Images are representative of ten images captured over three
experiments. Scale bar is 10 μm.
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residual (internalized) MerTK signal. Endocytosis was quantified as the amount of
fluorescence after acid-washing (internalized MerTK) divided by the fluorescence before
acid-washing (total MerTK). These efferocytosis assays were then used to investigate the
role of Src-family kinases, Syk kinase, and PI3K (all critical regulators of other
phagocytic receptors) in MerTK-mediated endocytosis.
As a negative control, MerTK on M0 primary human macrophages was labelled but not
crosslinked through the addition of an anti-MerTK antibody plus a monovalent Cy3labelled secondary Fab. Without crosslinking, MerTK showed the expected
plasmalamellar distribution on the surface (Figure 8A, top panel). Acid-washing removed
most of this MerTK labelling (Figure 8A, bottom panel, and Figure 8C), indicating that
little basal endocytosis of MerTK occurred and that Fcγ receptors were not being
significantly engaged. The cells were counterstained with Cy5-WGA to demarcate their
plasma membrane.
To stimulate MerTK on M0 macrophages, MerTK was activated through the addition of
an anti-MerTK antibody followed by crosslinking with divalent secondary Cy3conjugated F(ab’)2. As shown in the top panel of Figure 8B, crosslinking induced a
punctate distribution of MerTK reminiscent of endosomes. Acid-washing was unable to
remove this staining, confirming that MerTK had been internalized into an endosome-like
compartment (Figure 8B, bottom panel). Quantification of cells pre- versus post-acid
wash determined that 76 ± 17% of MerTK was internalized (Figure 8D).
Given that MerTK crosslinking was a viable model of MerTK internalization, I then
addressed whether its endocytosis is dependent on PI3K, Syk or Src-family kinases by
treating M0 primary human macrophages with inhibitors of those proteins. As before,
non-crosslinked MerTK was not endocytosed (Figure 9A). When MerTK was
crosslinked, endocytosis was detected even after acid-washing the cells (Figure 9B).
Treatment of MerTK-crosslinked M0 macrophages with the PI3K inhibitor LY294002,
the Syk inhibitor piceatannol, or the Src-family kinase inhibitor PP1, had no notable
impact on MerTK endocytosis after crosslinking (Figure 9C-E). Quantification of both
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Figure 8: Crosslinking MerTK on M0 primary human macrophages induces
endocytosis.
MerTK endocytosis was quantified by measuring total MerTK by fluorescence
microscopy, followed by removal of non-internalized MerTK staining with acid-washing
and re-imaging of the samples. The plasma membrane was demarcated with Wheat Germ
Agglutinin (WGA). A) Basal (non-crosslinked) endocytosis of MerTK. B) Endocytosis of
crosslinked MerTK (F(ab’)2) on M0 macrophages C) Quantification of MerTK mean
fluorescence intensity (MFI) of pre- versus post-acid washed, non-crosslinked condition.
The asterisk indicates statistical significance by one-tailed Student’s t-test (P < 0.05). D)
Quantification of MerTK MFI of pre- versus post-acid washed, MerTK-crosslinked cells.
n.s indicates no statistically significant difference between non-acid washed and acidwashed conditions; one-tailed Student’s t-test. Data are presented as mean + SEM.
Images are representative of three independent experiments. Scale bar is 10 μm.

51

A)
Merge

WGA

Acid-washed

Non-acid-washed

MerTK

Acid-washed Non-acid-washed

B)
MerTK

Merge

WGA

C)
100

80

60

40

*

20

0
N o n - a c id w a s h e d

A c id - w a s h e d

M e a n F lu o r e s c e n c e In t e n s ity

M e a n F lu o r e s c e n c e In t e n s ity

D)
300

n.s.

200

100

0
N o n - a c id w a s h e d

A c id - w a s h e d

52

MerTK mean fluorescence intensity (Figure 9F) and percent internalization (Figure 9G)
confirmed these results. These results demonstrate that endocytosis of MerTK is
independent of PI3K, Syk, and Src-family kinases.
To confirm the effectiveness of the inhibitors, the ability of the inhibitors to block the
well-established FcγR-mediated phagocytosis of IgG-coated beads was performed using
RAW macrophages. RAW macrophages were fed unlabelled IgG-coated beads and after
an internalization period, non-internalized beads were labelled with a Dylight 488conjugated secondary antibody (green). As expected, untreated cells readily
phagocytosed the majority of beads (Figure 10A, 10E) and FcγR-mediated phagocytosis
was considerably blocked by all three inhibitors, LY294002, piceatannol, and PP1
(Figure 10B-D, 10E).
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Figure 9: Endocytosis of MerTK is independent of Src/Syk-kinases and PI3K.
MerTK endocytosis was quantified by measuring total MerTK by fluorescence
microscopy, followed by removal of non-internalized MerTK staining with acid-washing
and re-imaging of the samples. The plasma membrane is demarcated by WGA. A)
Endocytosis of MerTK in unstimulated (Fab labelled) M0 macrophages. B) Endocytosis
assay of untreated MerTK-crosslinked (F(ab’)2) M0 macrophages. C-E) Endocytosis
assay of PI3K-inhibited (C, LY294002), Syk-inhibited (D, piceatannol), and Src-family
kinase-inhibited (E, PP1) MerTK-crosslinked macrophages. F) MerTK MFI pre and post
acid-washing on either untreated or inhibitor-treated M0 macrophages. G) Percent
MerTK internalization based on the data from panel F. All images are taken through 60X
objective. Scale bar is 10 μm. Data are presented as mean + SEM from three independent
experiments. Differences among means are not statistically significant by ANOVA with
Bonferroni correction.
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Figure 10: Inhibition of IgG-mediated
phagocytosis.
A)
DIC and 488 channel (green) images of IgG-mediated phagocytosis on untreated
RAW macrophages as positive control. B-D) DIC and 488 channel images of IgGmediated phagocytosis on B) PI3K, C) Syk, and D) Src-family kinase-inhibited
RAW264.7 macrophages. E) Phagocytic index of untreated, PI3K-inhibited (LY294002),
Syk-inhibited (piceatannol), and Src-family kinase-inhibited (PP1) RAW264.7
macrophages; (n = 1). Scale bar is 10 μm.
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3.7 Tyrosine phosphorylation of MerTK on M0 primary
human macrophages is partially dependent on Src/Syk
and PI3-kinase
Previous studies have shown that activating phagocytic receptors by crosslinking will
lead to phosphorylation of the downstream proteins which drive the internalization of the
phagocytic targets 69. Our results revealed MerTK endocytosis follows crosslinking, so
we investigated whether activating MerTK on M0 macrophages would also induce
tyrosine phosphorylation like that observed downstream of classical phagocytic receptors.
Phosphotyrosine (4G10) immunostaining of unstimulated M0 macrophages detected
typical patterns and levels indicative of basal protein phosphorylation, with the
phosphotyrosine immunostaining showing the punctuate staining typical of focal
adhesions that account for a large portion of basal phosphorylation (Figure 11A). As a
positive control we activated Fcγ receptors with aggregated IgG, which has been
previously established to trigger a large increase in tyrosine phosphorylation 69, and
observed the expected increase in numerous punctate phosphotyrosine structures on the
cells consistent with aggregated IgG-activated Fcγ receptors (Figure 11B).
When MerTK was labelled, but not crosslinked, through the addition of anti-MerTK plus
a Cy3-conjugated Fab antibody, basal levels of phosphorylation were observed (Figure
11C, top panel). Crosslinking MerTK with Cy3-conjugated F(ab’)2 appeared to increase
total cellular tyrosine phosphorylation (Figure 11C, bottom panel). We noticed that
enriched phosphotyrosine staining was only observed on cells with strong MerTK signal
(white arrows), consistent with this increase in phosphorylation being due to MerTK
crosslinking. To confirm these data, Pearson’s co-localization analysis of MerTK with
phosphotyrosine (4G10) staining was performed. The Pearson’s R-value was greatly
increased on MerTK crosslinked cells, indicating a strong co-localization of
phosphoproteins with MerTK (Figure 11D). Despite this strong co-localization after
crosslinking there was no statistically significant difference in the 4G10 mean
fluorescence intensity between basal and MerTK-crosslinked condition, although the data
trended towards increased phosphorylation (Figure 11E).
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Figure 11: Co-localization of MerTK and tyrosine-phosphorylated proteins on
M0 primary human macrophages in response to MerTK crosslinking.
A) Unstimulated M0 macrophages expressing MerTK were immunostained for tyrosinephosphorylated proteins (4G10, green). B) M0 macrophages stimulated with aggregated
human IgG were immunostained for tyrosine-phosphorylated proteins. C) MerTK on M0
macrophages were either unstimulated (Fab, top panel) or crosslinked (F(ab’)2, bottom
panel), then the cells were immunostained to detect tyrosine-phosphorylated proteins
(4G10, green). D) Pearson’s correlation coefficient between immunostaining of MerTK
and tyrosine-phosphorylated proteins (4G10) in images of unstimulated macrophages
(Fab) and MerTK-crosslinked macrophages (F(ab’)2). The asterisk indicates P < 0.05
compared with Fab by one-tailed Student’s t-test. Ten fields were analysed from four
experiments. E) Fold change of tyrosine-phosphorylated protein expression of
unstimulated (basal), aggregated human IgG (AgIgG), non-crosslinked MerTK (Fab), and
crosslinked MerTK (F(ab’)2) cells. Results are representatives of four experiments (n = 4
+ SEM). n.s. denotes no significant difference by ANOVA with Bonferroni correction.
Scale bar is 10 μm.
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Next, I assessed the impact of inhibiting PI3K, Syk, and Src-family kinases on MerTKinduced patterns of protein phosphorylation. Unstimulated or MerTK-crosslinked M0
macrophages were either left untreated or treated with the PI3K inhibitor LY294002, the
Syk inhibitor piceatannol, or Src-family kinase inhibitor PP1, and then immunostained
for phosphoproteins.
These inhibitors decreased the basal level of phosphorylation in unstimulated cells
(Figure 12A). As expected, all three inhibitors decreased phosphorylation in response to
Fcγ receptor activation of protein phosphorylation (Figure 12B). Unexpectedly,
crosslinking MerTK led to increased tyrosine phosphorylation (Figure 12C) that was
partially blocked by LY294002 and piceatannol (Figure 12D, E, respectively). PP1 was
also inhibitory of MerTK-mediated phosphorylation (Figure 12F), consistent with the
finding from Mero et al.
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. Quantification of the mean fluorescence intensity confirmed

that all three inhibitors induced a statistically significant inhibition of phosphorylation in
both aggregated human IgG-treated and MerTK crosslinked cells (Figure 12G). Pearson’s
co-localization analysis showed a similar trend, although PI3K inhibition did not reach
statistical significance (Figure 12H). These results demonstrate that MerTK tyrosine
phosphorylation in response to crosslinking is partially dependent on PI3K, Syk and Srcfamily kinases.
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Figure 12: MerTK tyrosine phosphorylation in response to receptor crosslinking
is partially dependent on Src/Syk-kinases and PI3K.
A) 4G10 immunostaining was performed on unstimulated M0 macrophages (top-left), or
unstimulated M0 macrophages treated with a PI3K inhibitor (LY294002, top-right), Syk
inhibitor (piceatannol, bottom-left), or Src-family kinase inhibitor (PP1, bottom-right). B)
4G10 immunostaining was performed on M0 macrophages stimulated with aggregated
human IgG. Cells were either left untreated or treated with PI3K, Syk or Src-family
kinase inhibitors. C) MerTK on untreated M0 macrophages was activated with Cy3tagged F(ab’)2 antibody then cells were immunostained for phosphotyrosine. D-F)
MerTK on D) PI3K-inhibited (LY294002), E) Syk-inhibited (piceatannol) or F) Srcfamily kinase-inhibited (PP1) M0 macrophages was crosslinked using a Cy3-tagged
F(ab’)2 antibody (red) and the cells were immunostained for phosphotyrosine (4G10). G)
Phosphotyrosine MFI of basal, aggregated human IgG, and MerTK-crosslinked (F(ab’)2)
cells either left untreated or treated with inhibitors. Data are means + SEM for each
condition, from two experiments. H) Pearson’s correlation coefficient was measured
between MerTK and phosphotyrosine on MerTK-crosslinked M0 macrophages that were
either uninhibited or treated with inhibitors for PI3K, Src-family kinase or Syk. n.s.
indicate non-statistically significant decrease in co-localization of MerTK with 4G10.
Asterisks indicate statistically significant changes (P < 0.05) by ANOVA with
Bonferroni correction. Scale bar is 10 μm.
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3.8 Crosslinking MerTK on M0 primary human
macrophages promotes tyrosine phosphorylation
Immunoblotting was used to further investigate MerTK-mediated protein
phosphorylation. Cell lysates from M0 macrophages that were either unstimulated,
depleted of focal contact phosphorylation by EGTA treatment, treated with aggregated
human IgG as a positive control, or MerTK-crosslinked, were separated by SDS-PAGE
and immunoblotted for tyrosine-phosphorylated proteins. Increased tyrosine
phosphorylation was noted when MerTK was crosslinked (Figure 13), although it was
much smaller in magnitude and impacted a small number of proteins than did aggregated
human IgG-induced phosphorylation. Moreover, a phosphoband at approximately 125
kDa corresponding to MerTK was apparent on the immunoblot (Figure 13, arrow),
suggestive of MerTK autophosphorylation. This led us to conclude that crosslinking
MerTK induces phosphorylation of a small subset of downstream proteins.

3.9 Activation of MerTK on M0 macrophages followed by
immunoprecipitation of phosphorylated proteins
Next, I wanted to identify the proteins being phosphorylated in response to MerTK
crosslinking through immunoprecipitation and mass spectrometry. M0 macrophages were
either left unstimulated or MerTK was crosslinked, then cell lysates were incubated with
4G10 (anti-phosphotyrosine) conjugated agarose beads followed by elution of the
proteins, separation on SDS-PAGE and detection by coomassie staining. Despite several
attempts and multiple troubleshooting steps, we were unable to recover phosphoproteins
from these cell lysates (Figure 14). I suspect this failure to recover phosphoproteins was
likely due to a combination of the low expression of MerTK (relative to other receptors
such as FcγRIIA), which in turn produced a weak induction protein phosphorylation after
crosslinking. This was further aggravated by the limited number of macrophages we can
produce from a single blood preparation. Consequently, we are reattempting the cloning
of MerTK to create a cell line which expresses higher levels of MerTK, in the hopes that
such a cell line would produce a higher level of MerTK-dependent phosphorylation and
thus provide a viable model for the purification of phosphoproteins.
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Figure 13: Crosslinking MerTK on M0 primary human macrophages promotes
tyrosine phosphorylation.
Phosphotyrosine (4G10) immunoblot of cell lysates from basal, EGTA-treated,
aggregated human IgG (AgIgG)-treated, and MerTK crosslinked (MerTK x-link) M0
macrophages. Arrow indicates a phosphoband of the same molecular mass as MerTK.
Actin was immunoblotted (below) to ensure equal loading. Blot is representative of four
similar experiments.
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Figure 14: Activation of MerTK and immunoprecipitation of tyrosinephosphorylated proteins.
Phosphotyrosine immunoprecipitates (pY IP) were prepared from unstimulated (basal) or
MerTK-crosslinked (MerTK x-link) M0 primary human macrophages. The gel shown is
representative of six similar experiments.
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When successful, this model will be used to identify proteins phosphorylated in response
to MerTK ligation through immunoprecipitation of the phosphorylated proteins, followed
by identification by mass spectrometry.
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Chapter 4: Discussion
4.1 MerTK signalling in efferocytosis
Efferocytosis is important for the maintenance of cellular homeostasis as it prevents
autoimmunity and inflammation caused by the release of alarmins and autoantigens from
uncleared apoptotic cells. MerTK is a major efferocytic receptor and studies have shown
that MerTK mutations impair efferocytosis, leading to accumulation of apoptotic cells
and the subsequent pathogenic release of alarmins and autoantigens through secondary
necrosis 34,35,41. The importance of MerTK was first identified in the retina, where MerTK
is vital for proper clearance of shed photoreceptor outer segments by retinal pigment
epithelial (RPE) cells. This discovery was made in the RCS rat model which has a
recessively inherited retinal degeneration caused by a mutation in the MerTK gene 35,70.
Similar mutations are found in individuals with retinitis pigmentosa, further highlighting
the importance of MerTK in maintenance of the retina 37.
MerTK plays a similarly important role in other tissues, but it should be noted that the
importance of MerTK relative to other efferocytic receptors varies between tissues. For
example, the accumulation of apoptotic cardiomyocytes is not impaired in MerTK
deficient animals as there are other efferocytic receptors that compensate for the absence
of MerTK 71. However, defective MerTK signalling in mice bone marrow macrophages
has been shown to promote accumulation of apoptotic cells in models of atherosclerosis,
leading to inflammation-accelerated atherosclerosis 42. For example, in a study by Thorp
et al. 43, in a mouse model of atherosclerosis, MerTK mutation reduced clearance of
apoptotic cells and promoted necrosis within the atherosclerotic plaque. In other models,
MerTK has been found to be crucial for prevention of autoimmunity. In particular,
MerTK mutations and the resulting failure to clear apoptotic cells produces an SLE-like
disease driven by impaired efferocytosis 40. MerTK signalling is critical to prevent this
pathology, as mice lacking only the intracellular kinase domain of MerTK also develop
lupus-like autoimmunity 3.
Little is known of MerTK’s signalling pathway; with all signalling discovered to date
elucidated using the RPE phagocytosis model. Shelby et al. 26 evaluated MerTK
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interactions with SH2-domain containing proteins and detected MerTK interactions with
Grb2, Vav3, PIK3R1, and Src. Src activation was detected downstream of MerTK and
siRNA knockdown of Grb2 impaired efferocytosis of photoreceptor outer segment. Their
findings suggest that SH2-domain proteins are integral part of MerTK signalling in RPE,
but also account for all of what is known of MerTK signalling in the context of
efferocytosis.
I hypothesized that MerTK signalling occurs through a pathway unique from that utilized
by conventional phagocytic receptors such as FcγR and αmβ2. The rational for this
hypothesis was two-fold, namely 1) other studies have not identified a role for the
proteins normally involved in these phagocytic pathways downstream of MerTK, and 2)
MerTK signalling and the resulting efferocytosis is immunologically silent, while
conventional phagocytosis is pro-inflammatory and immunogenic. Both of these findings
strongly suggest that MerTK is not signalling through the same signalling pathways used
by conventional phagocytic receptors.

4.2 MerTK expression
MerTK expression had previously been reported in J774.1 murine macrophages 68, but
we were unable to observe consistent MerTK expression in this cell line despite using
multiple detection techniques and culture conditions. This inconsistency in expression
suggest that MerTK expression is regulated by unknown cell culture conditions such as
cell density or the levels of particular cytokines within the fetal bovine serum used to
prepare the culture media. RAW264.7 and ANA-1 murine macrophages were not found
to express MerTK, nor could signalling in response to MerTK crosslinking be detected in
ANA-1 cells (Figure 3E). Other studies have suggested that these murine cell lines are
constitutively differentiated into an M1 macrophage phenotype 72, which our results
indicate weakly express MerTK (Figure 6). This differentiation may also explain the poor
MerTK expression in J774.1, RAW264.7 and ANA-1 cells.
Our failure to identify endogenous MerTK expression in murine cell lines necessitated
the generation of ectopic MerTK-expressing cells. To date, no other studies have used an
ectopic expression system of full-length MerTK like the one I attempted to develop.
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Indeed, I am aware of only open study which used recombinant MerTK, and that study
only used the intracellular kinase domain of the gene 71. The lack of ectopic expression
tools is probably due to the apparent toxicity of the MerTK gene to the DH5α
Escherichia coli cells used in all of our cloning approaches. Indeed, we have only ever
recovered MerTK clones mutated such that the transmembrane/intracellular portions of
the protein would not be expressed (Figure 4C), consistent with these domains being
toxic if expressed in E. coli. Consequently, our future work may attempt to clone MerTK
using yeast cells (eukaryotic cells) as they are more likely to be able to support constructs
expressing proteins with eukaryotic-specific motifs such as the secretion signals required
for the proper localization of transmembrane domains 73.
This study then used primary human macrophages as model system for elucidating
MerTK signalling. Peripheral blood mononuclear cells were differentiated into M0, M1,
and M2 macrophages through culturing the cells in the presence of specific growth
factors and environmental stimuli. These differentiation protocols are well-established
and have been verified by flow cytometry 74,75. M0 macrophages were generated by
culturing with M-CSF and closely resembled the phenotype of macrophages resident in
healthy tissues. Indeed, M0 macrophages are thought to represent the subtype of
macrophages involved in tissue homeostasis 76. M1 macrophages were generated by
culturing monocytes with GM-CSF, LPS, and IFN-γ, and are considered to be classically
activated, pro-inflammatory cells like those found at the sites of bacterial infections 76,77.
M2 macrophages differentiate in the presence of M-CSF plus anti-inflammatory
cytokines such as IL-4, and are considered to be alternatively activated towards a
phenotype that suppresses inflammation and promotes cell growth and tissue repair 76,77.
Immunofluorescence analysis was performed on differentiated macrophages to identify
endogenous MerTK. I hypothesize that MerTK will be present on anti-inflammatory and
homeostatic (M2 and M0) primary macrophages. As expected, MerTK labelling was
observed in the M0 and M2 subtypes (Figure 6). M0 cells were used for subsequent
experiments because these cells are relatively undifferentiated and retain a strong
capacity for phagocytosis 76. My results slightly conflict with the observations of Zizzo et
al. 78, who observed MerTK expression on all subtypes of human macrophages, but with
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greatly enriched MerTK expression on the anti-inflammatory M2c subtype. This subtype
of M2 macrophages is formed in the presence of M-CSF and glucocorticoid steroid
hormones, and represents a cell that is further differentiated compared to the M2
phenotype induced in my experiments. Indeed, I found MerTK expression on M0
macrophages as well as M2 macrophages without further differentiation into the M2a/b/c
subtypes, while contrary to this study, did not observe MerTK on M1 cells. The
discrepancy is likely attributable to differences in the cell differentiation methods used by
us versus Zizzo et al. 78. Specifically, M-CSF was used in all differentiation media used
by Zizzo et al. 78, while we used M-CSF only in M0 and M2 cultures. This suggests that
MerTK may be an M-CSF inducible gene – a possibility undergoing further investigation
in our lab.
Since different in vitro culture methods lead to differences in MerTK expression in cells
supposedly differentiated to the same subtype, it will be necessary in the future to assess
MerTK in macrophages isolated from M0, M1, and M2-like in vivo environments.
Regardless, the observed expression of MerTK on M0 and M2 macrophages in my study
(Figure 6) is consistent with these cell types needing to engage in efferocytosis as a
homeostatic (M0) or tissue remodelling (M2) mechanism. The absence of MerTK on M1
macrophages (Figure 6) would be consistent with wanting to avoid efferocytosis by cells
actively involved in inflammation and antigen presentation.

4.3 Elucidating MerTK signalling
I first attempted to elucidate MerTK signalling using beads that would selectively engage
MerTK in a manner that mimics the particulate nature of apoptotic bodies. Challenges
were encountered while assessing the efferocytic ability of MerTK using this antibodycoated bead model as I was unable to selectively engage MerTK without co-stimulating
Fcγ receptors on the macrophages (Figure 7). Such a bead-based model is preferable to
crosslinking assays as it recapitulates the particulate nature of apoptotic cells. Indeed,
studies of phagocytosis have demonstrated that while both crosslinking and bead-based
assay activate the same signalling pathways, the apparent role of these pathways in
internalization can be different for crosslinked receptors (example, endocytosis) versus
particulate targets (phagocytosis). For example, PI3K is activated by both crosslinking
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Fcγ receptors and by IgG-coated beads but is only required for the uptake of IgG-coated
beads with a diameter greater than 3μm 24,51. Even if these bead-based assays worked,
they likely would have been incomplete as it may have been difficult to incorporate αvβ5specific antibodies or ligands into this bead-based model, making it hard to assess the
cooperation of MerTK with integrins 58,79.Therefore, it is critical in the future that we
generate a MerTK-specific activation model involving a particulate target that
incorporates both MerTK-specific and integrin-specific components.
Apoptotic cells plus exogenously-produced MerTK-specific opsonins were considered,
but will not suffice as they will express a range of “eat me” signals 9,15, including some
which can be engaged by receptors such as TIM-4 that are capable of directly binding to
and internalizing apoptotic cells independently of any opsonins 22. Therefore, future
studies will clone the MerTK-specific opsonin, Gas-6, and the integrin-specific opsonin,
MFG-E8 (lactadherin) 14. Once they are purified, these proteins can be coated onto
polystyrene beads singularly or together in order to create MerTK-specific, integrinspecific, or dually-specific efferocytotic targets. This tool would allow us to selectively
engage MerTK or αvβ5 integrin alone or together, enabling a better differentiation of their
function in MerTK-mediated efferocytosis and signalling pathways.
Although we were unable to create a MerTK-specific particulate target, it is well
established that crosslinking phagocytic receptors induces the same signalling pathways
as does a particulate target engaging the same receptor 69. For example, the efferocytic
receptor, CD36, has been shown to signal and endocytose upon crosslinking with antiCD36 IgA and a secondary F(ab’)2 antibody using the same pathways required for CD36mediated phagocytosis of pathogens, and uptake of other particulates such as oxidized
LDL 19. Similarly, we were able to induce endocytosis by crosslinking MerTK with a
F(ab’)2. F(ab’)2 was used to avoid stimulating Fcγ receptors present on macrophages,
which specifically recognize the Fc region of antibodies that is removed during
preparation of F(ab’)2 fragments 19. Using this model, we assessed the role of Src-family
kinases, Syk, and PI3K on MerTK-mediated endocytosis and phosphotyrosine signalling
(Figures 9, 12).
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Our studies identified a significant decrease in MerTK-induced protein phosphorylation
when PI3K activity was inhibited (Figure 12D). Despite this, PI3K inhibition had no
impact on the endocytosis of crosslinked MerTK (Figure 9C). This is consistent with the
observations of Cox et al. 51, who determined that Fcγ receptor-mediated phagocytosis
required PI3K-induced actin polymerization. They found that the PI3K inhibitors,
LY294002 and wortmannin, prevented Fcγ receptor-mediated phagocytosis and
pseudopod extension. Importantly, LY294002 and wortmannin only inhibited the
phagocytosis of particles greater than 3μm suggesting that PI3K is necessary for
engulfment of particles greater than 3μm but not smaller ones 51. This size-dependent
effect may explain the lack of PI3K involvement in MerTK endocytosis, as the MerTKinduced PI3K activity may only be required for internalization of particulate targets.
Much to our surprise Src-family kinase/Syk inhibition had no impact on MerTK
endocytosis (Figure 9E and 9D, respectively). This was surprising as inhibition of these
proteins typically blocks internalization through most phagocytic receptors independent
of particle size, including in assays of antibody-mediated receptor crosslinking 19,58,80.
Oddly, Src-family kinase and Syk inhibition reduced total phosphorylation induced by
MerTK crosslinking (Figure 12F and 12E, respectively) suggesting that while MerTK
was activating the Src-family kinase/Syk kinase pathway, a novel Src-family kinase/Syk
independent pathway was being used to mediate MerTK internalization. Given these
results, I predict that future studies using a MerTK-specific bead-based assay will
identify a role of PI3K for engulfment of MerTK-specific particles greater than 3μm in
diameter, while Src-family kinase/Syk will not be involved in the uptake of these
particulate targets.
The signalling patterns of MerTK varied from that used by Fcγ receptors in more than the
requirement for Src/Syk-family kinases. Indeed, both immunofluorescence and
immunoblotting revealed that MerTK had a much smaller impact on the change in
protein phosphorylation than did Fcγ receptor signalling (Figures 11B, 11C, and Figure
13). Immunoblotting confirmed that MerTK activation led to phosphorylation of a
smaller number of proteins than did aggregated IgG (Figure 13), and moreover, increased
phosphorylation was observed only proximal to MerTK without significant changes
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observed at the whole cell level (Figure 11C and 11E). This suggests that MerTK is
phosphorylating only a small portion of proximal proteins, without the cell-wide changes
in phosphorylation patterns observed downstream of Fcγ receptor engagement. I
attempted to identify these MerTK-phosphorylated proteins using a phosphotyrosine
immunoprecipitation (Figure 14), but the low level of protein phosphorylation induced by
endogenous MerTK stymied this experiment. Therefore, in the future we aim to generate
cells ectopically expressing MerTK at a high level, allowing for an induction of MerTKdependent phosphorylation that is sufficient for phosphotyrosine immunoprecipitation.

4.4 Implications of MerTK signalling in health and disease
It is evident that MerTK plays an important role in efferocytosis and homeostasis as
MerTK mutations are associated with the accumulation of apoptotic cells, development
of lupus-like autoimmunity, and worsening of inflammatory diseases such as
atherosclerosis 3,42,43,71. We have discovered that MerTK is expressed in M0 and M2
macrophage subtypes (Figure 6), which is expected as these cell types are known to play
a homeostatic role in clearing apoptotic cells and tissue remodelling after injury 81. These
findings are interesting in the context of atherosclerosis, as it is well established that M1
cells are common in the atherosclerotic plaque, suggesting that inappropriate
differentiation of macrophages to an M1 phenotype within the vascular intima may be a
critical step in the development of an atheroma 78,81,82.
We have also discovered that MerTK is internalized upon activation through a pathway
independent of the common regulators of phagocytosis. Interestingly, a portion of the
MerTK signalling is dependent on these signalling molecules, even though the
internalization of MerTK is not. Although further elucidation of MerTK signalling
pathway is required to better understand what is occurring, these findings suggest that
anti-inflammatory or anti-autoimmune therapies targeting the Src/Syk pathway should
not impair efferocytosis through MerTK. Such therapies may be of great benefit, given
the central role of Src-family kinase and Syk in mediating inflammatory processes 83.
Indeed, there is strong evidence linking Src-family kinases to acute inflammatory
signalling, with animal studies demonstrating that inhibitors of Src-family kinases reduce
acute inflammation and tissue injury 83–85.
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Our data also has implication in autoimmune disease. Previous studies have shown that
knockout mice lacking MerTK or its opsonins develop autoimmune disease, suggestive
that any defect in MerTK signalling may result in autoimmunity 3. Indeed, we hope that
our continued study of MerTK signalling may identify critical signalling pathways which
become impaired during the induction of autoimmunity. Identification of these pathways
may lead to pharmacological targets for prevention or treatment of autoimmune disease.
One such pathway may be the Src/Syk pathway assessed in this thesis. Indeed, we
observed that MerTK induced phosphorylation via Src-family kinase and Syk, but that
MerTK internalization was independent of these kinases. If this observation holds true,
this may offer to opportunity to inhibit autoimmune responses by blocking components of
the Src-family kinase/Syk signalling pathway without blocking efferocytosis. This would
therefore allow us to block Src-family kinase signalling, which is previously established
to be associated with autoimmunity 86, without reducing the clearance of apoptotic cells
and thus avoiding further complications due to poor apoptotic cell clearance.
PI3K is also linked with inflammation and autoimmunity, for instance Barber et al. 87 and
Camps et al. 88 discovered inhibitors that blocked PI3Kγ complex, reduced
glomerulonephritis, lupus, and rheumatoid arthritis in mouse models. However, PI3K is
not as viable a target as it may be required for the uptake of particulate targets, and
therefore PI3K inhibition may block some aspects of autoimmunity while at the same
time augment autoantigen and alarmin release through reducing efferocytosis.
Lastly, because MerTK is internalized independently of the commonly used Src/Syk
pathway, full elucidation of the MerTK signalling pathway will require an undirected
approach such as the immunoprecipitation of tyrosine-phosphorylated proteins attempted
in my final objective (Figure 14). Such an assay would allow for identification of the
pathways lying downstream of MerTK activation, with follow-up assays such as siRNA
knockdown of the identified signalling molecules used to assess the role of the proteins in
MerTK-mediated efferocytosis. The significance of these future studies is that they will
provide insights into MerTK’s function under homeostatic conditions, and ultimately
provide the knowledge necessary to understand how MerTK is dysfunctional under
inflammatory (example, atherosclerotic) or autoimmune conditions. This research has the
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potential to identify novel therapeutic and preventative strategies for inflammatory and
autoimmune diseases through reversing defects in MerTK function or otherwise altering
MerTK-dependent signalling.
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Appendix

Figure A1: Plasmid maps of source and attempted MerTk mammalian expression
vectors. A-B) – source vectors for murine (A) pIRES2-EGFP MerTK from Addgene, and
human (B) pDONR233-MerTK from Addgene. C-E) attempted MerTK expression
vectors: C) Wild-type murine MerTK, D) GFP murine MerTK and E) wild-type human
MerTK. Plasmid maps A-B are from Addgene, all others were created with SnapGene
software.
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